Pharmaceutical Processing World
Since its establishment in 1984, Pharmaceutical Processing has been a key resource for professionals in the pharmaceutical, biopharmaceutical, and biotech sectors, offering updates, insights, and information on the latest technologies and services. From the stages of formulation to packaging and advanced manufacturing, Pharmaceutical Processing World delivers thorough coverage of the newest innovations and best practices in the industry. The publication also provides in-depth analysis on various aspects of the pharmaceutical sector, including new product launches, drug pricing trends, treatment developments, and regulatory updates. Each year, we feature the Big Pharma 50, which highlights the largest pharmaceutical companies and offers valuable information about their research and development investments, top-selling medications, and future drug candidates. Pharmaceutical Processing World’s editorial content addresses important issues in pharmaceutical manufacturing, covering topics such as outsourcing, contract development, smart manufacturing, and the advancements associated with Industry 4.0. We also delve into areas like biologics, biopharmaceutical products, and innovation within the pharmaceutical field. Our audience consists of chemical engineers, technicians, facility managers, and regulatory experts.
Outlet metrics
Global
#2491894
United States
#1179267
Health/Biotechnology and Pharmaceuticals
#1118
Articles
-
1 day ago |
pharmaceuticalprocessingworld.com | Chris Newmarker
Fujifilm Diosynth Biotechnologies, a major contract development and manufacturing organization (CDMO), has entered into a 10-year manufacturing supply agreement with Regeneron Pharmaceuticals, valued at over $3 billion. The deal has the Fujifilm subsidiary providing U.S.-based manufacturing for Regeneron, with planned expansions at Fujifilm’s large-scale biopharmaceutical manufacturing facility in Holly Springs, North Carolina.
-
1 week ago |
pharmaceuticalprocessingworld.com | Sean Whooley
Bayer announced today that it opened a 70,000-square-foot expansion at its Myerstown, Pennsylvania, facility. The grand opening of the state-of-the-art facility follows a $44 million investment in 2022. Bayer says it reflects its commitment to providing self-care solutions to consumers across North America while advancing meaningful engagement with the local community.
-
2 weeks ago |
pharmaceuticalprocessingworld.com | Sean Whooley
Novartis announced today that it plans to invest $23 billion over five years to expand its U.S.-based infrastructure. The company said its investment aims to ensure all key Novartis medicines for U.S. patients will be made in the U.S. Its financial commitment enables the company to expand on its current pharmaceutical manufacturing, research and technology presence across the company.
-
2 weeks ago |
pharmaceuticalprocessingworld.com | Sean Whooley
BDD announced today that it opened a new 122-square-meter GMP manufacturing facility at BioCity near Glasgow. The company opened its facility after two years of development following a successful inspection by the Medicines and Healthcare products Regulatory Authority (MHRA) last month. A £2 million funding round from existing investors facilitated the development of the state-of-the-art facility.
-
3 weeks ago |
pharmaceuticalprocessingworld.com | Sean Whooley
Ashland announced that it completed a $10 million expansion of its pharmaceutical manufacturing plant in Cabreúva, Brazil. The company plans to mark the occasion with a ribbon-cutting ceremony tomorrow, April 4. This investment significantly expands Ashland’s pharmaceutical footprint in the region and capabilities to meet increasing market demand for coated tablets in Latin America and Brazil.
Pharmaceutical Processing World journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Contact Forms
Contact Form
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →